Cite
HARVARD Citation
Davis, F. et al. (2023). GREM1 in HER2+ breast cancer: worse prognosis, larger tumours and more bone metastasis. European journal of surgical oncology. 49 (1), pp. e2-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Davis, F. et al. (2023). GREM1 in HER2+ breast cancer: worse prognosis, larger tumours and more bone metastasis. European journal of surgical oncology. 49 (1), pp. e2-. [Online].